Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-05-26
1989-03-28
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549263, 549327, 549328, A61K 31365, C07D30508, C07D30512
Patent
active
048164771
ABSTRACT:
The compounds of the following structural formula (I) ##STR1## ar 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase inhibitors and useful as antihypercholesterolemic agents for the treatment of disease in which the inhibition of cholesterol biosynthesis would be useful, such as arteriosclerosis, hyperlipidemia and familial hypercholesterolemia.
REFERENCES:
patent: 4358602 (1982-11-01), Umezawa et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4751237 (1988-06-01), Chabala et al.
Chemical Communications, 1970, p. 639 [(Chem. Abstracts; vol. 73 #55594j (1970)].
J. Chem. Soc. (c), 1971, pp. 3888-3891 [(Chem. Abstracts; vol. 76, #45686 p. (1972)].
Girotra Narindar N.
Graham Donald W.
Yang Shu S.
DiPrima Joseph F.
Hollrah Glennon H.
Merck & Co. , Inc.
Sudol Michael C.
Treanor Susan P.
LandOfFree
Antihypercholesterolemic .beta.-lactones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihypercholesterolemic .beta.-lactones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypercholesterolemic .beta.-lactones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659518